Thoughtful component selection for sensor-driven devices can help avoid pitfalls that can derail production, force recalls, and threaten profitability. Read more in Intricon’s latest @MD&DI article.
Our Chief Commercial and Technology Officer, Dave Liebl, delves into this topic in his latest article for Medical Design and Development. Learn how to give your wearable device the best chance of success.
Intricon is pleased to announce that Anthony Millar will join Intricon as Vice President of Global Operations. Anthony comes to Intricon with over 23 years of experience within the Medical Device, Drug/Device, and Biotech industries.
Intricon is proud to announce that CEO Scott Longval was named to the Twin Cities Business (TCB) Top 100 People…
An innovative medtech company was unable to bring its revolutionary product to market when its supplier failed to produce components to specification. Frustrated with an unresponsive vendor and costly delays, the company hired Intricon to rapidly resolve the issues.
Intricon was recently recognized by the Minneapolis / St. Paul Business Journal as a leading corporate philanthropist in Minnesota. The…
Sofia Vargas, Business Development Manager for Intricon Costa Rica, shares her insights on the greatest challenges and opportunities facing medtech today.
Learn more about optimizing EM sensor performance, cost, and manufacturability in this recent article by Intricon experts, published in Medical Design & Outsourcing.
Twin Cities Business spoke with Dave Liebl, Intricon’s Chief Commercial and Technology Officer, about the company’s strategic expansion into Costa Rica.
Intricon’s Chief Commercial and Technology Officer, Dave Liebl, was recently interviewed by Design News in conjunction with his presentation at MD&M Minneapolis. Check out these highlights from his talk.